North America

Ulu Ventures leads $3 mln round for Aromyx

Silicon Valley-based Aromyx, which applies biotechnology and data science to capture unique sensory data, has raised $3 million in financing. Ulu Ventures led the round with participation from Rationalwave Capital Partners, Merus Capital, CE Venture Capital, Stanford University and Radicle Growth.

Healthy Ventures to raise $50 mln for sophomore fund

Healthy Ventures is seeking to raise $50 million for its second fund, according to an SEC filing. The San Francisco-based venture firm targets infrastructure software in healthcare.

eSmart Systems procures $34.4 mln

Norway-based eSmart Systems, a provider of AI-based analytics for infrastructure inspection and asset health monitoring, has raised $34.4 million in funding. The investors included Energy Impact Partners and innogy Ventures.

GreatHorn takes in $13 mln

Waltham, Massachusetts-based GreatHorn, an email security platform provider, has secured $13 million in funding. The lead investors were RRE Ventures and .406 Ventures.

Healthcare services provider Remedy scores $10 mln Series A

Austin-based Remedy, a provider of healthcare services, has raised $10 million in Series A financing. Santé Ventures led the round.

Delve Labs picks up funding

Montreal-based Delve Labs, a cybersecurity software company, has raised an undisclosed amount of funding. The lead backers were 3dot6 Ventures and Desjardins Capital.

Blockchain API platform dfuse lands $4.6 mln in seed round

Dfuse, a Montréal-based blockchain application programming interface (API) platform, has closed a seed-stage financing, raising about $4.6 million (US$3.5 million). U.S. cryptofund Multicoin Capital and Intel Capital, the venture capital arm of U.S. chip maker Intel Corp, led the round. Diagram Ventures, which co-founded dfuse, BoxOne Ventures, Panache Ventures and White Star Capital also invested. Launched in 2018 by Marc-Antoine Ross, Richard Reiner, Alexandre Bourget and Mathieu Boulianne, dfuse has created a range of products to help developers build effective blockchain applications. The funds raised will be used to expand the platform and grow engineering and customer teams.

Encoded Therapeutics inks $104 mln Series C

South San Francisco-based Encoded Therapeutics Inc, a precision gene therapy company, has secured $104 million in Series C funding. The investors included Venrock, ARCH Venture Partners, Matrix Capital Management, Illumina Ventures and Altitude Life Science Ventures.

TissueTech snags $82.25 mln

Miami-based TissueTech Inc, a provider of therapeutic solutions for the ocular surface, wounds, surgery and other applications, has raised $82.25 million in financing. EW Healthcare Partners led the round.

Delve Labs raises follow-on financing led by 3dot6, Desjardins

Montréal-based cybersecurity software company Delve Labs has raised undisclosed follow-on financing. The round was led by 3dot6 Ventures, a U.S. cybersecurity venture capital firm, and Desjardins Capital, an investment arm of Desjardins Group. They were joined by BDC Capital. Delve Labs in 2016 closed a $1.5 million seed deal backed by Real Ventures and other investors. Founded in 2014, Delve Labs provides an artificial intelligence-enabled vulnerability management and prioritization solution to help businesses identify security issues, reduce risks and protect key assets. Led by CEO Gabriel Tremblay, the company will use the funds raised for go-to-market activities and further innovation.